©The Author(s) 2025.
World J Stem Cells. Sep 26, 2025; 17(9): 108049
Published online Sep 26, 2025. doi: 10.4252/wjsc.v17.i9.108049
Published online Sep 26, 2025. doi: 10.4252/wjsc.v17.i9.108049
Figure 3 Inhibition of melanin production by umbilical cord-derived mesenchymal stem cell-conditioned medium.
A: B16F1 cells cultured in B16F1 culture media with α-melanocyte-stimulating hormone and 10% adipose-derived mesenchymal stem cell or umbilical cord-derived mesenchymal stem cell-conditioned medium. Scale bar = 250 μm; B: Comparison of the amount of melanin synthesized by B16F1 cells cultured with 10% adipose-derived mesenchymal stem cell or umbilical cord-derived mesenchymal stem cell-conditioned medium. Data were quantified using enzyme-linked immunosorbent assay. ADMSC-CM: Adipose-derived mesenchymal stem cell-conditioned medium; UCMSC-CM: Umbilical cord-derived mesenchymal stem cell-conditioned medium.
- Citation: Ahn H, Han HS, Lee KH. Efficacy and safety of umbilical cord-derived mesenchymal stem cell-conditioned media for preventing and treating skin aging. World J Stem Cells 2025; 17(9): 108049
- URL: https://www.wjgnet.com/1948-0210/full/v17/i9/108049.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i9.108049